Chromogenic Factor VIII Inhibitor Bethesda Profile CHF8P

Synonyms

Allscripts (AEHR) Order Name

Chromogenic Factor VIII Inhibitor Bethesda Profile

Sunrise Clinical Manager (SCM) Order Name

Chromogenic Factor VIII Inhibitor Bethesda Prof

EPIC Order Name

Chromogenic Factor VIII Inhibitor Bethesda Profile

Clinical Info

Detecting the presence and titer of a specific factor inhibitor directed againstcoagulation factor VIII for patients on emicizumab (Hemlibra) Detecting the presence and titer of an inhibitor directed against factor VIII This test is not useful for detecting the presence of inhibitors directed against other clotting factors and will not detect the presence of lupus anticoagulants.

Specimen Type

Blood

Specimen Volume

Container

Light Blue Top Tube

Collection Instructions

Container Tube:  Light Blue Top Tube
Specimen: 2 mL Platelet Poor Plasma in two vials each with 1mL
Note:  Must be separated no longer then 4 hours after collection

Transport Instructions

Frozen

Specimen Stability

14 Days Frozen

Methodology

Chromogenic

Days Performed

TAT:  3-5 Days

Performing Laboratory

Mayo Medical Laboratories

CPT

85130
85335
85390
LOINC Code: 95121-0

PDM

245700

Result Interpretation

CHROMOGENIC Factor VIII Activity Assay

       Adults: 55.0-200.0%

Normal, full-term newborn infants or healthy premature infants usually have normal or elevated factor VIII.

BETHESDA TITER

     < or =0.5 Bethesda Units

Forms


edit